5QQO image
Entry Detail
PDB ID:
5QQO
Keywords:
HYDROLASE
Title:
FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(6R)-6-(3-chlorophenyl)-2-oxo-1,3-oxazinan-3-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Escherichia coli
PDB Version:
Deposition Date:
2019-05-20
Release Date:
2019-09-18
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.00 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 32 2 1
5QQO validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Coagulation factor XI
Chain IDs:A
Chain Length:244
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P03951 Pfam ID:PF00089 EC:3.4.21.27
Protein Blast
Polymer Type:polypeptide(L)
Description:MET-ASP-ASP-ASP-ASP-LYS-MET-ASP-ASN-GLU-CYS-THR-THR-LYS-ILE-LYS-PRO-ARG
Chain IDs:B (auth: H)
Chain Length:18
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P03951 Pfam ID:PF00089 EC:3.4.21.27
Ligand Molecules
EDO
NRJ
SO4
Primary Citation
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability.
Clark, C.G, Rossi, K.A, Corte, J.R, Fang, T, Smallheer, J.M, De Lucca, I, Nirschl, D.S, Orwat, M.J, Pinto, D.J.P, Hu, Z, Wang, Y, Yang, W, Jeon, Y, Ewing, W.R, Myers Jr, J.E, Sheriff, S, Lou, Z, Bozarth, J.M, Wu, Y, Rendina, A, Harper, T, Zheng, J, Xin, B, Xiang, Q, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Lam, P.Y.S, Quan, M.L, Wong, P.C, Wang, C, Woerner, F, Smallheer, J.M, Barbera, F.A, Bozarth, J.M, Brown, R.L, Harpel, M.R, Luettgen, J.M, Morin, P.E, Peterson, T, Ramamurthy, V, Rendina, A.R, Rossi, K.A, Watson, C.A, Wei, A, Zhang, G, Seiffert, D, Wexler, R.R, Hangeland, J.J, Friends, T.J, Rossi, K.A, Smallheer, J.M, Wang, C, Sun, Z, Corte, J.R, Fang, T, Wong, P.C, Rendina, A.R, Barbera, F.A, Bozarth, J.M, Luettgen, J.M, Watson, C.A, Zhang, G, Wei, A, Ramamurthy, V, Morin, P.E, Bisacchi, G.S, Subramaniam, S, Arunachalam, P, Mathur, A, Seiffert, D.A, Wexler, R.R, Quan, M.L, Corte, J.R, Fang, T, Hangeland, J.J, Friends, T.J, Rendina, A.R, Luettgen, J.M, Bozarth, J.M, Barbera, F.A, Rossi, K.A, Wei, A, Ramamurthy, V, Morin, P.E, Seiffert, D.A, Wexler, R.R, Quan, M.L, Pinto, D.J, Smallheer, J.M, Corte, J.R, Austin, E.J, Wang, C, Fang, T, Smith 2nd, L.M, Rossi, K.A, Rendina, A.R, Bozarth, J.M, Zhang, G, Wei, A, Ramamurthy, V, Sheriff, S, Myers Jr, J.E, Morin, P.E, Luettgen, J.M, Seiffert, D.A, Quan, M.L, Wexler, R.R, Hu, Z, Wong, P.C, Gilligan, P.J, Han, W, Pabbisetty, K.B, Bozarth, J.M, Crain, E.J, Harper, T, Luettgen, J.M, Myers Jr, J.E, Ramamurthy, V, Rossi, K.A, Sheriff, S, Watson, C.A, Wei, A, Zheng, J.J, Seiffert, D.A, Wexler, R.R, Quan, M.L, Smith 2nd, L.M, Orwat, M.J, Hu, Z, Han, W, Wang, C, Rossi, K.A, Gilligan, P.J, Pabbisetty, K.B, Osuna, H, Corte, J.R, Rendina, A.R, Luettgen, J.M, Wong, P.C, Narayanan, R, Harper, T.W, Bozarth, J.M, Crain, E.J, Wei, A, Ramamurthy, V, Morin, P.E, Xin, B, Zheng, J, Seiffert, D.A, Quan, M.L, Lam, P.Y.S, Wexler, R.R, Pinto, D.J.P, Corte, J.R, Fang, T, Pinto, D.J, Orwat, M.J, Rendina, A.R, Luettgen, J.M, Rossi, K.A, Wei, A, Ramamurthy, V, Myers Jr, J.E, Sheriff, S, Narayanan, R, Harper, T.W, Zheng, J.J, Li, Y.X, Seiffert, D.A, Wexler, R.R, Quan, M.L, Corte, J.R, Fang, T, Osuna, H, Pinto, D.J, Rossi, K.A, Myers Jr, J.E, Sheriff, S, Lou, Z, Zheng, J.J, Harper, T.W, Bozarth, J.M, Wu, Y, Luettgen, J.M, Seiffert, D.A, Decicco, C.P, Wexler, R.R, Quan, M.L, Corte, J.R, Yang, W, Fang, T, Wang, Y, Osuna, H, Lai, A, Ewing, W.R, Rossi, K.A, Myers Jr, J.E, Sheriff, S, Lou, Z, Zheng, J.J, Harper, T.W, Bozarth, J.M, Wu, Y, Luettgen, J.M, Seiffert, D.A, Quan, M.L, Wexler, R.R, Lam, P.Y.S, Wang, C, Corte, J.R, Rossi, K.A, Bozarth, J.M, Wu, Y, Sheriff, S, Myers Jr, J.E, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Quan, M.L, Pinto, D.J.P, Orwat, M.J, Smith 2nd, L.M, Quan, M.L, Lam, P.Y.S, Rossi, K.A, Apedo, A, Bozarth, J.M, Wu, Y, Zheng, J.J, Xin, B, Toussaint, N, Stetsko, P, Gudmundsson, O, Maxwell, B, Crain, E.J, Wong, P.C, Lou, Z, Harper, T.W, Chacko, S.A, Myers Jr, J.E, Sheriff, S, Zhang, H, Hou, X, Mathur, A, Seiffert, D.A, Wexler, R.R, Luettgen, J.M, Ewing, W.R, Hu, Z, Wang, C, Han, W, Rossi, K.A, Bozarth, J.M, Wu, Y, Sheriff, S, Myers Jr, J.E, Luettgen, J.M, Seiffert, D.A, Wexler, R.R, Quan, M.L.Show
Bioorg.Med.Chem.Lett. 29 126604 126604 (2019)
PMID: 31445854 DOI: 10.1016/j.bmcl.2019.08.008

Abstact

This manuscript describes the discovery of a series of macrocyclic inhibitors of FXIa with oral bioavailability. Assisted by structure based drug design and ligand bound X-ray crystal structures, the group linking the P1 moiety to the macrocyclic core was modified with the goal of reducing H-bond donors to improve pharmacokinetic performance versus 9. This effort resulted in the discovery of several cyclic P1 linkers, exemplified by 10, that are constrained mimics of the bioactive conformation displayed by the acrylamide linker of 9. These cyclic P1 linkers demonstrated enhanced bioavailability and improved potency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
5QQO